14th European Congress of Clinical Microbiology and Infectious ...

Poster Sessions Tuesday, May 4, 2004
P1693 Imipenem-cilastatin treatment of osteo -
articular infections caused by multiresistant
Gram-negative rods
M. Rottman, J.-N. Martin, P. Leclerc, E. Ronco,
A. Lortat-Jacob, J.-L. Gaillard, P. Piriou
(Garches, Boulogne Billancourt, F)
P1694 Staphyloccocus aureus versus Gram-negative
bacilli pyogenic vertebral osteomyelitis.
A clinical, biological and radiological
comparative study
M.A. Barón Ramos, E. Jimenez-Mejías, J.D. Ruiz
Mesa, J. Palomino-Nicás, J.M. Reguera Iglesias,
J. Chacón, J. Pachón, J.D. Colmenero
(Málaga, Seville, E)
P1695 Characterisation of Salmonella paratyphi
A strains with reduced susceptibility to
quinolone isolated from an outbreak in Korea
S. Lee, D. Kim, C. Chang, H. Kim (Busan, KOR)
P1696 Rise in isolation rates and nalidixic acid
resistance in Salmonella hadar due to
common strains among poultry and humans
L. Politi, P.T. Tassios, L.S. Tzouvelekis,
M. Lambiri, A. Kansouzidou, M. Pasiotou,
K. Mellou, N. Vakalis, J. Kourea-Kremastinou,
T. Panagiotopoulos, N.J. Legakis
(Athens, Thessalonica, Halkida, GR)
P1697 Investigation of clinical and laboratory
findings of antibiotic-associated diarrhoea
N. Yapar, A. Sener, B. Karaca, M. Yücesoy,
H. Tarakci, N. Cakir, A. Yüce (Izmir, TR)
P1698 Serotyping and susceptibility testing of
shigella isolates during summer outbreak
of 2003 in an Iranian hospital, Tehran
M. Rahbar, K. Bahar, B. Kia Darbandisari,
M. Deldari (Tehran, IR)
P1699 Characterisation, genomic location and
distribution of the cytolethal distending
toxin genes in Shiga toxin-producing
Escherichia coli strains of non-O157
serogroups
M. Bielaszewska, M. Fell, L. Greune, R. Prager,
A. Fruth, H. Tschäpe, M.A. Schmidt, H. Karch
(Munster, Wernigerode, D)
P1700 Vibrio cholerae in the South-East of Iran
H.A. Khazaei, N. Rezaei, G.R. Bagheri
(Zabol, Tehran, IR)
P1701 Neonatal septicaemia in dogs by Klebsiella
pneumoniae
A. Madio, G. Greco, M. Corrente, M. Totaro,
C. Desario, M. Campolo, G. Marsullo,
D. Buonavoglia (Valenzano, Naples, I)
page 136 Final Programme
13:00–14:00
Quinolones in vitro studies
P1702 Lower levels of in vitro nonsusceptibility
to Moxifloxacin compared to other fluoroquinolones
in Canadian clinical isolates
of Streptococcus pneumoniae
J. Powis, J. Fuller, O. Vanderkooi, K. Green,
D. Low – Canadian Bacterial Surveillance Network
P1703 Comparative bactericidal activity of
moxifloxacin, gatifloxacin, garenoxacin, and
levofloxacin at concentrations simulating
Cmax and 1 ⁄ 2 Cmax
H. Musgrave, S. Campbell, C. Howley,
R.J. Davidson (Halifax, CAN)
P1704 Comparative in vitro activity of fluoro -
quinolones against clinical isolates of
Streptococcus pneumoniae
R. Alonso, R. Cisterna (Vitoria-Gasteiz, Bilbao, E)
P1705 The relationship between the mutant
prevention concentration and killing by
ciprofloxacin and levofloxacin for clinical
isolates of Pseudomonas aeruginosa
J. Blondeau, G. Hansen (Saskatoon, CAN)
P1706 Activity of moxifloxacin against 12 selected
clinical B. fragilis strains compared with
seven other agents investigated by time-kill
kinetics
R. Schaumann, E. Rabenhorst, M. Funke,
A. Rodloff (Leipzig, D)
P1707 Selection of resistance in Pseudomonas
aeruginosa and Acinetobacter spp. by
levofloxacin and ciprofloxacin alone and in
combination with beta-lactams and an
aminoglycoside
E. De Vecchi, L. Drago, L. Nicola, A. Colombo,
M.R. Gismondo (Milan, I)
P1708 Mutant prevention concentrations of
ciprofloxacin and enrofloxacin against
Salmonella enterica in vitro
L. Randall, S. Cooles, M. Woodward
(New Haw, UK)
P1709 Comparative in vitro resistance of the new
fluoroquinolones among aerobic Gramnegative
bacilli resistant to amikacin in a
hospital setting: a three-year study
E. Arroyo, D. Vera, C. Rivera-Vazquez,
G. Gonzalez, S. Saavedra, J. Gutierrez,
C. Ramirez-Ronda (San Juan, PR)